What are the diagnostic criteria for heart failure with reduced ejection fraction (HFrEF) versus heart failure with preserved ejection fraction (HFpEF)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Diagnostic Criteria for HFrEF vs HFpEF

HFrEF is diagnosed when LVEF is ≤40%, while HFpEF requires LVEF ≥50% PLUS evidence of elevated left ventricular filling pressures (either spontaneous or provokable). 1

HFrEF Diagnostic Criteria

The diagnosis of HFrEF is straightforward and requires:

  • Clinical signs and symptoms of heart failure (dyspnea, fatigue, edema, orthopnea, paroxysmal nocturnal dyspnea)
  • LVEF ≤40% on echocardiography or other cardiac imaging 1

That's it. The LVEF threshold alone, combined with HF symptoms, establishes the diagnosis.

HFpEF Diagnostic Criteria

HFpEF diagnosis is more challenging and requires ALL of the following 1:

  1. Clinical signs and symptoms of heart failure
  2. LVEF ≥50%
  3. Objective evidence of elevated LV filling pressures, demonstrated by at least one of:
    • Elevated natriuretic peptides (BNP or NT-proBNP)
    • Echocardiographic evidence: E/e′ ratio ≥15
    • Invasive hemodynamic measurements showing elevated pulmonary capillary wedge pressure or LV end-diastolic pressure
    • Evidence during provocative testing (exercise echocardiography or fluid challenge)

Supporting Structural Evidence for HFpEF

While not absolutely required, structural heart disease findings strengthen the HFpEF diagnosis 1:

  • Increased left atrial volume index
  • Increased LV mass index
  • Other LV structural or functional alterations

The Middle Ground: HFmrEF

Patients with LVEF 41-49% are classified as HFmrEF (heart failure with mildly reduced ejection fraction). These patients require the same additional evidence of elevated filling pressures as HFpEF patients 1.

Critical pitfall: A single LVEF measurement in the mildly reduced range (41-49%) is insufficient—you must assess the trajectory over time. These patients are typically either improving from HFrEF or deteriorating toward it 1.

Key Diagnostic Nuances

Why HFpEF Needs More Than Just LVEF

The writing committee emphasizes that HF symptoms are nonspecific and overlap with many conditions. Normal natriuretic peptide levels do NOT exclude HFmrEF or HFpEF 1. This is why objective measures of cardiac dysfunction are mandatory for diagnostic specificity in preserved or mildly reduced EF categories.

When Diagnosis Remains Uncertain

If the diagnosis is still unclear after initial evaluation:

  • Exercise stress echocardiography with diastolic parameter assessment
  • Invasive hemodynamics at rest or with exercise, measuring pulmonary capillary wedge pressure, LV end-diastolic pressure, PA pressures, stroke volume, and cardiac output 1

The H2FPEF Score

For challenging HFpEF cases, the H2FPEF clinical composite score integrates 1:

  • Obesity
  • Atrial fibrillation
  • Age >60 years
  • Treatment with ≥2 antihypertensive medications
  • E/e′ ratio >9
  • PA systolic pressure >35 mm Hg

The score ranges 0-9, with odds of HFpEF doubling for each point increase.

Improved EF Category

Important distinction: Patients with previous LVEF ≤40% who improve to >40% are classified as HFimpEF (heart failure with improved ejection fraction), NOT as HFpEF, even if LVEF reaches >50% 1. These patients should continue HFrEF treatment, as EF can decrease after medication withdrawal.

Related Questions

Is heart failure with reduced ejection fraction (HFrEF) considered congestive heart failure?
Is heart failure with reduced ejection fraction (HFrEF) the same as systolic heart failure?
What are the differences between heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF), and how should each be managed?
In a 68-year-old man with hypertension, dyspnea, orthopnea, paroxysmal nocturnal dyspnea, blood pressure 170/100, basal crackles, S4 gallop, systolic murmur, echocardiographic ejection fraction 55% with left‑ventricular hypertrophy and no wall‑motion or valvular abnormalities, which diagnosis is most likely: heart failure with preserved ejection fraction, heart failure with reduced ejection fraction, ischemic cardiomyopathy, or cor pulmonale with right‑ventricular failure?
What are the recommendations from the American Society of Echocardiography (ASE) guideline from July 2025 for the treatment of heart failure with preserved ejection fraction (HFpEF)?
For a patient with a prior positive HPV DNA test and indeterminate colposcopy, who now, two years later, has a negative HPV test, what is the recommended next step in management?
Are duloxetine (Cymbalta) and Lexapro (escitalopram) the same medication?
Can the weekly subcutaneous semaglutide 1 mg pen be increased to the 1.7 mg dose?
What are the best practices for promoting skin healing in patients with Ehlers‑Danlos syndrome?
What creams or topical agents are recommended for managing fragile skin in a patient with Ehlers‑Danlos syndrome?
What is the optimal antibiotic therapy for bacterial prostatitis in a 70-year-old male?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.